- (PLX AI) – Novo Nordisk says Wegovy recommended for approval for the treatment of obesity by the European regulatory authorities.
- • Novo Nordisk expects to receive final marketing authorisation from the European Commission in approximately two months
- • The positive CHMP opinion is based on results from the STEP phase 3a clinical trial program
- • Wegovy was launched in the US in June 2021
Quelle: PLX AI